CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of two different doses of Consensus Interferon-Alpha
and Interferon Gamma-1b with or without ribavirin in patients with chronic hepatitis C who
are non-responders to PEG-IFN-a 2a or PEG-IFN-a 2b plus ribavirin.